GlassScriptPhysician profile
Aaron Todd Miller
NPI 1023084290
$1,082.50
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.10 · 2020: $243 · 2021: $306 · 2022: $342 · 2023: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $198.29 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $134.58 | 2019-2021 | |
| Glaxosmithkline, LLC. | $122.15 | 2022-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $90.43 | 2020-2023 | Wegovy |
| Eisai INC. | $66.52 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.79 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $42.79 | 2022 | |
| Amarin Pharma, INC. | $37.10 | 2020-2021 | |
| Amgen INC. | $35.41 | 2022-2023 | Repatha, Otezla |
| Lundbeck LLC | $35.17 | 2022-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $32.75 | 2022-2023 | Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $29.77 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.06 | 2022 | |
| Mylan Specialty L.P. | $25.24 | 2019-2021 | |
| Nevro Corp. | $22.51 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $20.25 | 2019 | |
| Optos, INC. | $18.14 | 2020 | |
| Exact Sciences Corporation | $15.72 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $15.54 | 2022 | |
| Pfizer INC. | $14.68 | 2021 | |
| Organogenesis INC. | $14.23 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.03 | 2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $11.39 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.